To ensure the industry can realize the potential of cell and gene therapies, we must develop improved solutions that reliably support the control and transport of critical CGT raw materials and products.
Get support for your team through visibility of process data, locally and across your manufacturing sites. Obtain greater oversight of day-to-day operations, receive text and email-alerts of equipment alarms, and produce electronic batch records.
Liquid bulk drug substance is of utmost value after manufacturing from Biopharma industries. The single use bag independent platform RoSS helps to avoid product loss through breakages through robust composition and makes it possible to introduce your flexible end-to-end solution in drug substance logistics.
This webinar describes how the implementation of Pharma 4.0 technologies across the industry offers the promise and opportunity to significantly improve many aspects of Biopharma manufacturing and supply chain capabilities. eData exchange is a critical aspect of realizing the full potential of these digital solutions.
Amittha Wickrema, Ph.D., Professor of Medicine, Director, Advanced Cellular Therapeutics Facility, University of Chicago, reviews the cold chain workflow from start to finish for a cellular therapy product.
If advanced therapies are to be scaled, their management at hospital sites has to be scalable. How can we take complexity out — making life easier for couriers, manufacturers and hospitals — and create a seamless supply chain?
This study focuses on the running costs and carbon emissions associated with cryopreservation equipment, comparing a liquid nitrogen (LN2)-free controlled-rate freezer with a typical liquid nitrogen-based system. The environmental implications of using liquid nitrogen for cell freezing are explored along with carbon emissions during the manufacture, transportation, and operation of LN2-free controlled-rate freezers.
This guide summarizes the science of thawing following conventional, slow freezing methods. We address how cell thawing has historically developed into the techniques used today, along with the physical and biological implications of key metrics and components, such as warming rate and ice structure. Also included are reviews of key studies from scientific literature and a consideration of the interactions between cooling and warming rates, as applicable to cell and gene therapies.